BIRZNIEKS GUNTHER (SVP, Business Development) sold 7.9% of their position (42.43K shares) of VANDA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $350.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/4/2026ACC: 0001702031-26-000002
Officer· SVP, Business Development
Since Mar 2026
-42.43K
Net shares
Net seller
$350.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
42.43K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−42.43K
Price / share
$8.27
Trade value
$350.73K
% of position
7.9%
3/2/2026
536.63K→494.20K
Total
Net shares
−42.43K
Net value
-$350.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −42.43K | $8.27 | $350.73K | 7.9% | 536.63K | 494.20K |
| Total | −42.43K | -$350.73K | ||||||
Derivative Transactions0
No derivative transactions reported